APOE modifies the association between Aβ load and cognition in cognitively normal older adults
Year: 2011
Type: article
Study design: Observational Study
Abstract: OBJECTIVE: To determine the relationship between β-amyloid (Aβ) load as measured by [(11)C]-Pittsburgh compound B (PiB) PET and cognitive function in cognitively normal older adults. METHODS: We studied 408 cognitively normal older adults who participated in the population-based Mayo Clinic Study of Aging (MCSA) from January 2009 through March 2011. The participants underwent PiB PET and neuropsychometric testing within 6 months. The association between PiB retention and cognitive function was measured by partial correlation and an interaction with APOE status was tested using linear regression after adjusting for age, sex, and education. RESULTS: Higher PiB retention was associated with cognitive performance (Spearman partial r = -0.18; p < 0.01), specifically the memory, language, attention/executive, and visual-spatial processing domains in the whole group of participants. The association between PiB retention and cognition was modified by the APOE status on linear regression analysis even after controlling for the differences in the distribution of PiB values among APOE ε4 carriers and noncarriers (p = 0.02). Cognitive performance was associated with the Aβ deposition in the frontal, temporal, and parietal lobe association cortices in APOE ε4 carriers on SPM analysis (p < 0.001). CONCLUSION: There is a modest association between PiB retention and cognitive function in cognitively normal older adults and this relationship between Aβ load and cognitive function is modified by APOE status. Whereas Aβ load is associated with greater cognitive impairment in APOE ε4 carriers, the cognitive function in APOE ε4 noncarriers is influenced less by the Aβ load, suggesting that APOE isoforms modulate the harmful effects of Aβ on cognitive function.
Source: Neurology
Institution: Mayo Clinic
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Robert Wood Johnson Foundation, Alzheimer's Association, Eli Lilly and Company, Pfizer, Baxter International, Mayo Foundation for Medical Education and Research, University of Cambridge, University of Oxford, Eisai, National Institutes of Health, Forest Laboratories, National Institute on Aging, National Cancer Institute, National Center for Research Resources
Awards: 1H MRS markers of MCI syndromes and common dementias, Pathological basis of MRS and DTI changes in neurodegenerative dementia, Alzheimers Disease Patient Registry, Evaluating and Extending Our Hypothetical Model of Alzheimer's Biomarkers, G6206414941, EXTRAMURAL RESEARCH FACILITIES IMPROVEMENT PROGRAM, G9000038603
OpenAlex ID: W1994787669
